Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-12-13

Clinical Trial Update: Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports the completion of a study evaluating quetiapine (Seroquel) as therapy for substance use disorders in patients with schizophren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: Creighton University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED